Clinical trial
Combination Therapy for Atopic Dermatitis
NCT00119158 · Children's Hospital of Philadelphia, Other · Completed
Key facts
| NCT number | NCT00119158 |
|---|---|
| Title | Combination Therapy for Atopic Dermatitis |
| Official title | An Exploratory Double-blind, Randomized, Vehicle-controlled, Paired Study to Evaluate the Efficacy and Safety of Concomitant Use of Elidel Cream 1% and Cutivate Cream 0.05% in Patients With Severe Lesions of Atopic Dermatitis (AD) |
| Lead sponsor | Children's Hospital of Philadelphia, Other |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis |
| Intervention type | Drug |
| Interventions | Combination of pimecrolimus and fluticasone, pimecrolimus |
| Enrollment | 90 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Jul 13, 2005 |
| Last update posted | Jul 27, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: